Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Pathogenesis of type 2 diabetes mellitus
2004
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
2008
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Inflammation and metabolic disorders
2006 StandoutNature
The role of dopamine in motivation for food in humans: implications for obesity
2002
Inflammatory links between obesity and metabolic disease
2011 Standout
Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors
2004
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals
2006
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Cushing's syndrome
2015 Standout
Obesity, adipocytokines, and insulin resistance in breast cancer
2004
Cabergoline monotherapy in the long-term treatment of Cushing's disease
2010
Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes
2006
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Epidemiology of Parkinson's disease
2006 Standout
Mechanisms of obesity-associated insulin resistance: many choices on the menu
2007
IKK-β links inflammation to obesity-induced insulin resistance
2005
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
TLR4 links innate immunity and fatty acid–induced insulin resistance
2006 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Adipokines in inflammation and metabolic disease
2011 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Hexosamines as mediators of nutrient sensing and regulation in diabetes
2002
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
2004
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
2001
Short‐term effects of repetitive arm work and dynamic exercise on glucose metabolism and insulin sensitivity
2005
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes
2004
Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle
2000
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
Exploiting drug-disease relationships for computational drug repositioning
2011
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Dopaminergic drugs in type 2 diabetes and glucose homeostasis
2015
O-GlcNAc modification of nucleocytoplasmic proteins and diabetes
2005
Cardiovascular effects of melanocortins
2011
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients
2004
Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *
2005
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
2007 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
2005
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice
2002
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Exercise and Physical Activity for Older Adults
2009 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-α with Insulin Resistance
2008
Adiponectin and Adiponectin Receptors
2005 Standout
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
2004
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
2004
Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1
2002
Targeting orphan G protein‐coupled receptors for the treatment of diabetes and its complications: C‐peptide andGPR 146
2016
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
2001
Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
2002
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
2017
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity
2003
Inflammatory Mechanisms in Obesity
2011 Standout
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
2005
β-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1
2004 StandoutNobel
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
2001
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
2011
Interactions of Impaired Glucose Transport and Phosphorylation in Skeletal Muscle Insulin Resistance
2001
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
2000
Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners
2012 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Effect of Weight Loss on Liver Free Fatty Acid Uptake and Hepatic Insulin Resistance
2008
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Works of Ruben Pipek being referenced
Effects of Insulin on Subcellular Localization of Hexokinase II in Human Skeletal Musclein Vivo1
1998
UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues
1997
Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients
2003
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis
2001
Bromocriptine: a novel approach to the treatment of type 2 diabetes.
2000
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
1998